Skip to content
Top Globe News – Lifestyle
Author:
Dignify Therapeutics
Dignify Therapeutics Doses First Healthy Participant in Phase 1 Study of DTI-117 for Neurogenic Bowel Dysfunction
November 18, 2026
Dignify Therapeutics Advances into Clinic with FDA Clearance of IND for DTI-117 in Neurogenic Bowel Dysfunction
October 7, 2026